期刊文献+

嗜麦芽窄食单胞菌临床感染因素及其耐药性分析

An analysis of the resistance and infectious factor of the Stenotrophomonas maltophilia
下载PDF
导出
摘要 目的分析嗜麦芽窄食单胞菌的临床感染因素及其耐药性分布,有效地防止其感染和合理地指导临床用药。方法采用法国生物梅里埃VTTEK32全自动细菌分析系统(VTTEK-AMS)对77株嗜麦芽窄食单胞菌进行鉴定和手工药物分析。结果77株嗜麦芽窄食单胞菌对多种抗生素耐药,但对替卡西林/棒酸、头孢哌酮/舒巴坦、复方新诺明、环丙沙星的耐药性较低。而且,宿主因素和医源性因素与嗜麦芽窄食单胞菌的临床感染密切相关。结论嗜麦芽窄食单胞菌呈现多重耐药性,且感染率有所增加,临床上应对嗜麦芽窄食单胞菌的耐药性高度重视,以减少其感染的机会。 Objective To analyse the drug resistance of the Stenotrophomonas maltophilia and the cause of the clinical infection in order to prevent effectually infection and guide rational drug using in clinic. Methods 77 strains of Stenotrophomonas maltophilia were identified and carried on manual pharmaceutical analysis with the index of the V'Iq'EK system. Results 77 strains of the Stenotrophomonas maltophilia showed multi-drug resistant to polyantibiotic, hut the resistant ratios of tiearcillin- clavulanic acid, cefoperazone-sulbactam, SMZ-TMP, ciprofloxacin were lower. Moreover, host factor and iatrogenic factor were associated with the clinical infection of Stenotrophomonas maltophilia, Conclusions Stenotrophomonas maltophilia are multi-drug resistant with increasing of the infectious rate. The drug resistance of Stenotrophomonas maltophilia should be thought highly of in clinic for decreasing the chance of infection.
机构地区 江西省人民医院
出处 《江西医学检验》 2006年第6期503-504,507,共3页 Jiangxi Journal of Medical Laboratory Sciences
关键词 嗜麦芽窄食单胞菌 感染因素 耐药性 Stenotrophomonas maltophilia infectious factor Drug resistance
  • 相关文献

参考文献4

二级参考文献25

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 3Munter RG,Yinnon AM,Schiesinger Y,et al.Infective endocarditis due to Stenotrophomonas maltophilia.Eur J Clin Mirobiol Infect Dis,1998,17:353-356.
  • 4National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Susceptibility Testing,Twelfth Informational Supplement[S]. 2003 ,M100-S13.
  • 5Jae-Hoon Song. Pneumococcal Resistance to Beta-Lactams and Macrolides[C]. International Symposium on Antimicrobial Agents and Resistance, 2003,30-33.
  • 6Center for diseases prevention &epidemiology. oregon health division. Vancomycin-resistant enterococcal infections[J]. C D summary, 1997,46:1.
  • 7EARSS Annual Report 2002[EB/OL]. http://www. earss.rivm. nl.
  • 8Wang H, KelKar S, Wu W, etal, Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases:prevalence of CTX-M-3 at a hospital in China[J]. Antimicrob Agents chemother, 2003,47: 790-793.
  • 9Chanawong A,MZali FH, Heritage J. et al. Three cefortaximases, CTX-M-9, CTX-M-13 and CTX-M-14, among Enterobacteriaceae in the People's Republic of China[J]. Antimicrob Agents Chemother, 2002,46: 630-637.
  • 10周庭银,赵虎,于军一,周晔,陈险峰,曾万杰.重症监护病房临床标本1129株病原菌的分析[J].中华传染病杂志,2000,18(2):127-129. 被引量:34

共引文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部